At a glance
- Originator Novartis
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 23 Nov 1995 Discontinued-Preclinical for Inflammation in Switzerland (Unknown route)